Genomics startups, backed by advances in precision medicine and personal genetic profiling, are gaining attention in the healthcare industry. Companies such as Element Biosciences, Deep Genomics, Human Longevity, NantOmics, Nucleome Therapeutics, Ultima Genomics, and Variant Bio are using innovative techniques and technologies to enhance disease prevention and treatment. These developments are expected to contribute to the genomics market, projected to reach $66.8 billion by 2029.
M&S boss urges shoppers to visit stores in person as it battles cyber-attack – The Guardian
Marks & Spencer’s CEO, Stuart Machin, apologized for recent service disruptions caused by a cyber attack, assuring customers that the company is working tirelessly to
